New hope for lung cancer patients: experimental drug JYP0322 takes on chemo
Disease control
Not yet recruiting
This study tests a new drug called JYP0322 against standard chemotherapy for people with a specific type of advanced lung cancer (ROS1-positive non-small cell lung cancer) that has stopped responding to earlier targeted treatments. About 207 participants will be randomly assigned…
Phase: PHASE3 • Sponsor: Guangzhou JOYO Pharma Co., Ltd • Aim: Disease control
Last updated May 17, 2026 05:30 UTC